The Board of Directors of BlueOcean NutraSciences announced that its interim CEO, Gavin Bogle, has been appointed as CEO of the company. Gavin's appointment will be effective on October 1, 2014. His North American nutraceutical and pharmaceutical industry experience and networks are an ideal fit for the company's three product platform development requirements.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.02 CAD | +33.33% | 0.00% | -71.43% |
1st Jan change | Capi. | |
---|---|---|
-71.43% | 14.27L | |
-7.65% | 10TCr | |
-17.29% | 828.89Cr | |
+29.92% | 509.98Cr | |
+9.29% | 433.89Cr | |
+38.06% | 304.32Cr | |
+80.65% | 219.72Cr | |
-12.91% | 124.16Cr | |
-8.91% | 64Cr | |
+1.92% | 55Cr |
- Stock Market
- Equities
- GROW Stock
- News CO2 Gro Inc.
- BlueOcean NutraSciences Appoints Gavin Bogle as CEO, Effective on October 1, 2014